[
    [
        {
            "time": "2018-11-13",
            "original_text": "智通港股公告精选︱(11.13)腾讯前三季股东应占盈利增11%至717.28亿元",
            "features": {
                "keywords": [
                    "腾讯",
                    "盈利",
                    "增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智通港股公告精选︱(11.13)腾讯前三季股东应占盈利增11%至717.28亿元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-11-11",
            "original_text": "更美APP发布医美消费榜：2019年双11当日订单量同比增长7倍",
            "features": {
                "keywords": [
                    "医美",
                    "消费",
                    "增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗美容"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "更美APP发布医美消费榜：2019年双11当日订单量同比增长7倍",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 2
            }
        },
        {
            "time": "2019-12-12",
            "original_text": "12日晚公告精编丨獐子岛未知扇贝死亡具体原因，海康威视董事被立案调查 其他违规处罚",
            "features": {
                "keywords": [
                    "獐子岛",
                    "扇贝死亡",
                    "海康威视",
                    "立案调查"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "农业",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "12日晚公告精编丨獐子岛未知扇贝死亡具体原因，海康威视董事被立案调查 其他违规处罚",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-01-01",
            "original_text": "复星医药(02196)获Mimivax授权使用其专利和专有知识商业化肿瘤免疫治疗产品SurVaxM",
            "features": {
                "keywords": [
                    "复星医药",
                    "肿瘤免疫",
                    "授权"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196)获Mimivax授权使用其专利和专有知识商业化肿瘤免疫治疗产品SurVaxM",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-01-02",
            "original_text": "复星医药(02196.HK)获Mimivax授予新型肿瘤免疫治疗产品独家权",
            "features": {
                "keywords": [
                    "复星医药",
                    "独家权",
                    "肿瘤免疫"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)获Mimivax授予新型肿瘤免疫治疗产品独家权",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-01-03",
            "original_text": "复星医药(600196.SH)：子公司获肿瘤免疫治疗产品SurVaxM区域性独家开发及商业化授权",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "授权"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：子公司获肿瘤免疫治疗产品SurVaxM区域性独家开发及商业化授权",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-01-04",
            "original_text": "复星医药(600196.SH)：复星医药产业获Mimivax许可",
            "features": {
                "keywords": [
                    "复星医药",
                    "许可",
                    "产业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：复星医药产业获Mimivax许可",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-01-05",
            "original_text": "艾德证券期货：市场缺乏热点 恒指大概率震荡磨底",
            "features": {
                "keywords": [
                    "市场",
                    "热点",
                    "恒指",
                    "震荡"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "艾德证券期货：市场缺乏热点 恒指大概率震荡磨底",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-11-12",
            "original_text": "格隆汇港股通5日资金流入流出排行榜 | 11月12日",
            "features": {
                "keywords": [
                    "港股通",
                    "资金流入",
                    "资金流出"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "格隆汇港股通5日资金流入流出排行榜 | 11月12日",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]